New option available for Alzheimer’s patients as FDA approves expanded drug use
- Posted on May 12, 2026
- By AOL
- 0 Views
- 1 min read
New option available for Alzheimer’s patients as FDA approves expanded drug use
The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major milestone for patients.
